Replacement Director/PDMR Shareholding

RNS Number : 9665S

Dr. Martens PLC

14 March 2023

 

A number of non-material typographical changes have been made to the Director/PDMR Shareholding announcement released on 14 March 2023 at 15:19 under RNS No. 9571S. The changes are identified with an asterisk (*). The full amended text is shown below.

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it was notified on 14 March 2023 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').

The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.

On 13 March 2023, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 140.20 pence per share and were granted allocations of Matching Shares (for no consideration) in the quantities set out   in the table below:

Director / PDMR	Number of Partnership Shares purchased	Number of Matching Shares awarded
Kenny Wilson	107*	107*
Jon Mortimore	107*	107*

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Kenny Wilson
2	Reason for the notification
a)	Position/status	PDMR (Chief Executive Officer)
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Dr. Martens plc
b)	LEI	213800QPT8YM6NQZPH28
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24
b)	Nature of the transaction	1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s) 1. 140.20p 107* 2. Nil 107*
d)	Aggregated information - Aggregated volume - Price - Aggregated volume - Price	1. Partnership shares 107* 140.20p 2. Matching shares 107* Nil
e)	Date of the transaction	13 March 2023
f)	Place of the transaction	1. London Stock Exchange (XLON) 2. Outside of a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jon Mortimore
2	Reason for the notification
a)	Position/status	PDMR (Chief Financial Officer)
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Dr. Martens plc
b)	LEI	213800QPT8YM6NQZPH28
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24
b)	Nature of the transaction	1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s) 1. 140.20p 107* 2. Nil 107*
d)	Aggregated information - Aggregated volume - Price - Aggregated volume - Price	1. Partnership shares 107* 140.20p 2. Matching shares 107* Nil
e)	Date of the transaction	13 March 2023
f)	Place of the transaction	1. London Stock Exchange (XLON) 2. Outside of a trading venue

For further information please contact:

Rebecca Flaherty

Company Secretarial Assistant

[phone]

 

END

 

 

DSHSFIFWLEDSESD